REQUEST A DEMO
Total
USD $0.00
Search more companies

Apotheka Pharma Vaistine UAB (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: Apotheka Pharma Vaistine UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Apotheka Pharma Vaistine UAB is an enterprise in Lithuania, with the main office in Kaunas. The company operates in the Pharmacies and Drug Stores sector. The company was established on January 21, 2019. Apotheka Pharma Vaistine UAB currently employs 45 (2025) people. There was a net sales revenue drop of 8.87% reported in Apotheka Pharma Vaistine UAB’s latest financial highlights for 2025. The enterprise’s net profit margin decreased by 1.34% in 2025.

Headquarters
Karmelavos sen. Martinavos k. Martinavos g. 8
Kaunas; Kaunas County; Postal Code: LT-54475

Contact Details: Purchase the Apotheka Pharma Vaistine UAB report to view the information.

Basic Information
Total Employees:
Purchase the Apotheka Pharma Vaistine UAB report to view the information.
Registered Capital:
Purchase the Apotheka Pharma Vaistine UAB report to view the information.
Financial Auditors:
Purchase the Apotheka Pharma Vaistine UAB report to view the information.
Incorporation Date:
January 21, 2019
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apotheka Pharma Vaistine UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.87%
Total operating revenue
-8.87%
Net Profit (Loss) for the Period
6.37%
Total Equity
-25.71%
Net Profit Margin
-1.34%
Return on Equity (ROE)
-7.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?